TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Advance ZincTek Limited ( (AU:ANO) ).
Advance ZincTek Limited has received feedback from the U.S. Food and Drug Administration (FDA) following a routine inspection, highlighting several compliance issues related to Good Manufacturing Practice (GMP). These issues pertain to supplier qualification, precursor handling processes, and digital record-keeping systems, among others. The company has stated that there is no impact on the supply to U.S. customers and no concerns about product quality. In response, Advance ZincTek plans to engage U.S. regulatory consultants to ensure alignment with FDA requirements, provide additional GMP training, and increase investment in compliance efforts. The company is committed to resolving all outstanding observations and will keep stakeholders informed of any significant developments.
The most recent analyst rating on (AU:ANO) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Advance ZincTek Limited stock, see the AU:ANO Stock Forecast page.
More about Advance ZincTek Limited
Average Trading Volume: 6,093
Technical Sentiment Signal: Hold
Current Market Cap: A$74.86M
See more insights into ANO stock on TipRanks’ Stock Analysis page.